NCT01888354View on ClinicalTrials.gov

Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Multiple Sclerosis (MS)
Interventions
DRUG

H.P. Acthar Gel (repository corticotropin injection)

Acthar Gel 80 IU

Trial Locations (2)

77030

The University of Texas-Houston Neurology Clinic, Houston

92056

The MS Center at the Neurology Center in Southern California, Oceanside

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT01888354 - Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations | Biotech Hunter | Biotech Hunter